Scaling Spray-Dried Dispersions for Commercial Success: Enabling Medicines Through Scale, Capacity, and Supply Resilience

(SDDs) are playing an increasingly important role in improving bioavailability. But developing an effective formulation is only part of the challenge. Commercial success also requires preserving product quality through scale-up while securing the capacity and supply resilience needed to meet future demand.

Explore how drug developers can connect formulation decisions, process development, technology transfer, and commercial manufacturing into a cohesive SDD strategy. Learn why commercial planning should begin well before Phase 3, how process modeling and scale-connected equipment can reduce uncertainty, and which capabilities to consider when selecting a manufacturing partner.

The webinar also examines Lonza’s planned PSD4 expansion in Bend, Oregon, including large-scale spray-drying suites designed to support higher-volume commercial programs and future growth. Discover how early planning, scientific understanding of critical process parameters, and manufacturing continuity can help reduce transfer risk, support reliable launches, and create a more resilient path from development through long-term commercial supply.

Watch the full webinar to explore strategies for scaling SDD programs with commercialization in mind.